Antibiotic treatment of patients with term premature rupture of membranes
| dc.contributor.author | Ovalle, A | |
| dc.contributor.author | Gómez, R | |
| dc.contributor.author | Martinez, MA | |
| dc.contributor.author | Giglio, MS | |
| dc.contributor.author | Bianchi, R | |
| dc.contributor.author | Diaz, L | |
| dc.contributor.author | Sáez, J | |
| dc.contributor.author | Poblete, JP | |
| dc.contributor.author | Romero, R | |
| dc.date.accessioned | 2025-01-21T01:32:24Z | |
| dc.date.available | 2025-01-21T01:32:24Z | |
| dc.date.issued | 1998 | |
| dc.description.abstract | Background/objective Subclinical microbial invasion of the amniotic cavity in patients with premature rupture of membranes (PROM) at term occurs in 34% of cases and is a risk factor for puerperal endometritis. This study was conducted to determine whether antibiotic administration to women with PROM at term could reduce the rate of infection-related morbidity. | |
| dc.description.abstract | Study design Between August 1990 and December 1993, patients with term PROM were randomly allocated to receive either cefuroxime-clindamicin or placebo. | |
| dc.description.abstract | Results Fifty-five patients received intravenous antibiotics and 50 patients received placebo. Patients allocated to the antibiotic group had a lower incidence of maternal infection-related morbidity (clinical chorioamnionitis and puerperal endometritis) than patients who received placebo (1.8% (1/55) vs. 16% (8/50), respectively, p < 0.05). No significant differences were found in other maternal and neonatal outcomes between the two groups. | |
| dc.description.abstract | Conclusion Administration of antibiotics to patients with PROM at term results in a significant reduction in the rate of maternal infection-related morbidity. | |
| dc.fuente.origen | WOS | |
| dc.identifier.issn | 1359-8635 | |
| dc.identifier.uri | https://repositorio.uc.cl/handle/11534/97255 | |
| dc.identifier.wosid | WOS:000078273000016 | |
| dc.issue.numero | 6 | |
| dc.language.iso | en | |
| dc.pagina.final | 606 | |
| dc.pagina.inicio | 599 | |
| dc.revista | Prenatal and neonatal medicine | |
| dc.rights | acceso restringido | |
| dc.subject | rupture of membranes | |
| dc.subject | intra-amniotic infection | |
| dc.subject | chorioamnionitis | |
| dc.subject | puerperal endometritis | |
| dc.subject | antibiotics | |
| dc.subject | randomized clinical trial | |
| dc.subject.ods | 03 Good Health and Well-being | |
| dc.subject.ods | 05 Gender Equality | |
| dc.subject.odspa | 03 Salud y bienestar | |
| dc.subject.odspa | 05 Igualdad de género | |
| dc.title | Antibiotic treatment of patients with term premature rupture of membranes | |
| dc.type | artículo | |
| dc.volumen | 3 | |
| sipa.index | WOS | |
| sipa.trazabilidad | WOS;2025-01-12 |
